PMC55 IMPACT OF THE FDA DRAFT GUIDANCE ON PATIENT REPORTED OUTCOMES (PRO) LABEL CLAIMS FOR APPROVED DRUG PRODUCTS IN THE US- HAS IT MADE A DIFFERENCE?

May 1, 2009, 00:00
10.1016/S1098-3015(10)73206-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)73206-X/fulltext
Title : PMC55 IMPACT OF THE FDA DRAFT GUIDANCE ON PATIENT REPORTED OUTCOMES (PRO) LABEL CLAIMS FOR APPROVED DRUG PRODUCTS IN THE US- HAS IT MADE A DIFFERENCE?
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73206-X&doi=10.1016/S1098-3015(10)73206-X
First page :
Section Title :
Open access? : No
Section Order : 619
Categories :
Tags :
Regions :
ViH Article Tags :